Cantargia Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Damian Marron
Chief executive officer
SEK 350.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 1.7yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO
Damian Marron (62 yo)
no data
Tenure
SEK 350,000
Compensation
Mr. Damian Marron, Ph.D. is Independent Chair of Nicox S.A. from July 2024. He is an Entrepreneur-In-Residence at Loxbridge Research LLP. He serves as Director of Resolys Bio, Inc. Damian has a strong trac...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Director | no data | SEK 350.00k | no data | |
| Founder & Scientific Advisor | no data | SEK 355.00k | no data | |
| Founder & Scientific Advisor | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Chief Financial Officer | 1.7yrs | no data | 0.030% € 7.6k | |
| Chief Scientific Officer | 1.7yrs | no data | 0.014% € 3.5k | |
| Executive Assistant of Administration & Finance | 3.2yrs | no data | no data | |
| Chief Medical Officer | 2.5yrs | no data | no data | |
| Chief Business Officer | less than a year | no data | no data | |
| Financial Controller | 3.2yrs | no data | no data |
1.7yrs
Average Tenure
59yo
Average Age
Experienced Management: 7V3's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Director | 3.8yrs | SEK 350.00k | no data | |
| Independent Chairman of the Board | 9.1yrs | SEK 854.00k | 0.10% € 26.3k | |
| Independent Director | 6.8yrs | SEK 473.00k | 0.027% € 6.9k | |
| Independent Director | 3.8yrs | SEK 342.00k | 0.054% € 13.8k | |
| Independent Director | 4.3yrs | SEK 550.00k | no data |
4.3yrs
Average Tenure
64yo
Average Age
Experienced Board: 7V3's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/17 02:03 |
| End of Day Share Price | 2025/02/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cantargia AB (publ) is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arvid Necander | Carnegie Investment Bank AB |
| Soo Romanoff | Edison Investment Research |
| null null | Life Sciences Research International BV |